iCAN Serving Patients and Doctors in China

Sep 28, 2015, 16:28 ET from Cancer Action Now, Inc.

MORRISTOWN, N.J., Sept. 28, 2015 /PRNewswire/ -- As part of its mission to improve clinical outcomes of those diagnosed with cancer through the innovative use of technology, iCAN China, LLC, a wholly owned subsidiary of US based Cancer Action Now, Inc. (iCAN) has partnered with HuKang, Inc. to provide physicians in China immediate access to top US cancer experts.  It is estimated that over 3 million individuals are diagnosed with cancer each year in China*.  This is nearly twice the number of individuals diagnosed in the US annually+.  iCAN is positioned to address significant issues in China: access to local and international cancer experts and timely treatment.

In partnership with HuKang, iCAN China offers rapid access to a group of multispecialty physicians in the US, including many of the top oncologists and surgeons.  It offers physicians in China, on behalf of their respective patients, access to the latest treatment options and care plans.  Connectivity with iCAN is easy.  Upon completing the registration and verification process, physicians may immediately access the iCAN virtual, proprietary and secure technology platform.  "As the incidence of cancer increases and technology advances, this international collaboration is poised to enhance clinical outcomes.  We are proud to offer our network of US cancer experts to physicians in China by working with HuKang," said Charles Balch, MD, President of iCAN International.

"We are pleased to partner with HuKang as it gives us access to the largest market in the world while advancing our mission of facilitating the use of technology to improve cancer care.  Importantly, iCAN physicians uniquely hold expertise in a wide range of cancers necessary to foster optimal treatment in an expedited manner regardless of situation," said iCAN CEO, Jeff Meehan.

"We are excited partner with Cancer Action Now so that physicians in China, on behalf of their patients, can have a direct line to top cancer experts in the US," said HuKang CEO, Li Chen.  "Through technology, this partnership is expected to help providers optimize outcomes among cancer patients." 

Please call 844-GET-iCAN or email manderson@canceractionnow.com for more information about iCAN services or visit our website at http://www.canceractionnow.com

About Cancer Action Now, Inc.

The mission of iCAN is to help cancer patients and their doctors achieve optimal health care treatment by providing fast, customized information about their cancer management from top cancer experts.  iCAN's carefully chosen network of cancer experts offers collective expertise with a common goal of improving cancer outcomes by facilitating the use of technology and enabling immediate communication of up-to-date clinical information.  This empowers physicians and patients to more rapidly make decisions and initiate optimal treatment earlier, regardless of location.  iCAN, through a proprietary, HIPAA compliant and secure platform, connects providers, patients and caregivers with many of the top cancer experts in the US who are prepared to evaluate a wide range of cancer cases.  iCAN experts intend to ease concerns, answer questions and provide clear information.  Please visit www.canceractionnow.com or connect with iCAN on Facebook, Twitter, LinkedIn and Pinterest.

About HuKang, Inc.

HuKang Medical and Technology, located in HangZhou China, is focused on providing quality services to top medical professionals.  HuKang provides two services for hospitals and physicians.  First, they match large metropolitan area physicians, willing to work a second position and handle heavy caseloads, with hospitals in need of quality physicians in less populated areas. Second, they enhance cancer care in China by providing local area oncologists and their patients' access to leading cancer physicians and surgeons with international reputations through iCAN. HuKang is focused on providing these valuable services to physicians and oncologists, in China, in order to enhance the level of care and clinical outcomes.  Please visit http://www.1bangyi.com for more information.

Cancer Action Now Media Contact:
Maud Anderson
manderson@canceractionnow.com

HuKang Media Contact:
Hannah Yuan
yuanyuwen@1bangyi.com

* WHO, International Agency for Research on Cancer, Globocan 2012, estimated cancer incidence, mortality and prevalence worldwide in 2012

+ American Cancer Society. Cancer Facts and Figures 2015.  Atlanta, GA 2015

SOURCE Cancer Action Now, Inc.



RELATED LINKS

http://www.canceractionnow.com